TipRanks
Go Ultimate55% OFF

Welltower (WELL) AI Stock Analysis

MX:WELL

Welltower

(BMV:WELL)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Operating growthStrong same-store NOI growth, particularly in senior housing operations, indicates that existing assets are producing materially higher earnings. Continued occupancy gains, pricing power, and revenue growth can support durable internal growth and strengthen portfolio performance over the next several quarters.
Negative Factors
Operating-profit volatilityThe sharp decline in EBIT margin indicates that operating costs or non-recurring items are absorbing more of the company’s revenue at the operating-profit level. If sustained, this volatility could limit earnings conversion and make reported profitability less predictable.

Welltower (WELL) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%MX:WELL+31.19%SPY+13.13%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 169.09B
Dividend Yield
1.33%
Average Volume (3M)
927
Price to Earnings (P/E)
113.3
Beta (1Y)
0.17
Revenue Growth
24.80%
EPS Growth
-142.07%
Country
Mexico
Employees
712
Sector
Real Estate
Sector Strength
65
Industry
REIT - Healthcare Facilities

Welltower Business Overview & Revenue Model

Company Description

Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care,...

Welltower Earnings Call Summary

Earnings Call Date:Oct 25, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 15, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Welltower reported exceptional earnings growth, record-level same-store NOI performance, improving occupancy and pricing power, substantial investment activity, disciplined capital allocation, and a strong balance sheet. Management also highlighted significant macroeconomic, interest-rate, credit-market, debt-maturity, and skilled nursing challenges, but described the balance sheet and operating model as positioned to navigate volatility. The highlights significantly outweighed the lowlights.

Positive Updates

Strong Third-Quarter Earnings Growth
Revenue increased 38%, adjusted EBITDA increased 35%, and FFO per share grew nearly 25%. Normalized FFO was $1.67 per share, representing 24.6% year-over-year growth.

Negative Updates

Deteriorating Macroeconomic and Geopolitical Environment
Management said the macroeconomic environment continued to deteriorate. Inflation reaccelerated to 3.7% in September, markets were pricing more rate hikes rather than cuts, the 30-year Treasury reached 5.3% in August, the 10-year Treasury touched 5.36%, and attacks on Gulf energy infrastructure pushed oil back above $100 per barrel.

Company Guidance

Welltower updated its full-year 2026 outlook to net income attributable to common stockholders of $3.31 to $3.37 per diluted share and normalized FFO of $6.47 to $6.53 per share, or $6.50 per share at the midpoint, representing 22.9% normalized FFO per share growth for 2026; the $0.10 increase at the midpoint comprises a $0.03 increase from senior housing operating NOI, a $0.055 increase from investment and financing activity, and a 1.5-cent increase from FX and income tax, slightly offset by higher expected G&A. The outlook assumes total portfolio year over year same store NOI growth of 15% to 16.25%, driven by outpatient medical of 2% to 3%, long term post acute of 2% to 3%, senior housing triple net of 3.5% to 4.5%, and senior housing operating of 20.25% to 21.75%, including revenue growth of 9.3%, RevPOR growth of 5.1%, a year over year 350-basis-point increase in occupancy, expense growth of 4.6%, and ExpPOR growth of approximately 60 basis-points; year-end net debt to adjusted EBITDA is expected to end in the low 3x range, and approximately $1.9 billion of expected dispositions position Welltower to fund approximately $7.7 billion of incremental investment activity.

Welltower Risk Analysis

Welltower disclosed 47 risk factors in its most recent earnings report. Welltower reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Welltower Peers Comparison

Overall Rating

UnderperformOutperform
Sector (65)

Financial Indicators

MX:WELL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
OHIOHI80Outperform$14.24B16.2616.51%5.73%15.18%72.69%
DOCDOC71Outperform$13.45B54.373.30%6.41%5.52%48.98%
VTRVTR70Outperform$45.81B157.091.89%2.41%22.13%0.00%
AHRAHR68Neutral$11.75B78.623.67%1.87%16.39%―
Sector *65Neutral$2.17B12.193.79%4.94%3.15%1.96%
HRHR60Neutral$6.26B-129.94-1.04%5.19%-6.28%77.63%

* Real Estate Sector Average

Performance Comparison

0%10%20%30%MX:WELLDOCOHIVTRHRAHRDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:WELL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:WELLWelltower, Inc.4314.711025.8531.19%
DOCHealthpeak Properties, Inc.19.032.6115.90%
OHIOmega Healthcare Investors46.985.8014.09%
VTRVentas Inc84.8011.6815.98%
HRHealthcare Realty Trust Incorporated18.491.7510.46%
AHRAmerican Healthcare REIT, Inc.53.528.4618.78%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.